Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option?

SIMPLE SUMMARY: The optimal neoadjuvant treatment modality for locally advanced gastroesophageal junction (GEJ) adenocarcinoma is still debated. Although chemoradiotherapy is set as the standard of treatment for squamous cell cancer, offering high rates of complete clinical and histologic response,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zandirad, Eric, Teixeira Farinha, Hugo, Barberá-Carbonell, Beatriz, Geinoz, Sandrine, Demartines, Nicolas, Schäfer, Markus, Mantziari, Styliani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736946/
https://www.ncbi.nlm.nih.gov/pubmed/36497338
http://dx.doi.org/10.3390/cancers14235856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736946/
https://www.ncbi.nlm.nih.gov/pubmed/36497338
http://dx.doi.org/10.3390/cancers14235856

Ejemplares similares